Morepen Laboratories Limited (BOM:500288)
52.27
-0.10 (-0.19%)
At close: Jun 16, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 28.64 billion as of June 16, 2026. Its market cap has decreased by -21.54% in one year.
Market Cap
28.64B
Enterprise Value
29.81B
Revenue
18.06B
Ranking
n/a
PE Ratio
30.21
Stock Price
52.27
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 28.64B, an increase of 230.81%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 28.64B | 27.27% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 46.35B |
| Gufic Biosciences | 37.23B |
| Novartis India | 32.19B |
| Unichem Laboratories | 31.41B |
| Kwality Pharmaceuticals | 25.91B |
| Venus Remedies | 24.08B |
| Hikal | 22.68B |
| Amrutanjan Health Care | 16.12B |